ALC Trading Analysis - 10/13/2026 03:32 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge context for Alcon Inc. (ALC) suggests the following themes that may be relevant to current price softness:

• Alcon reported steady surgical and vision-care demand in prior quarters, but FX headwinds and softer elective-procedure volumes in some regions have pressured guidance.
• Recent med-tech sector rotation has favored defensives; ALC's low beta (0.43) has limited downside relative to peers but also capped rallies.
• No major near-term ALC-specific catalyst (e.g., FDA decision or M&A) is widely known; next earnings are typically tied to fiscal-year-end (2025-12-01 per fundamentals).
• Broader market caution on healthcare valuations may explain the bearish options positioning observed in the embedded data.

This news context is separate from the data-driven sections below and is provided only as background.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for ALC:

• Trailing P/E is 49.10 with trailing EPS of 1.31; valuation is elevated versus typical med-tech peers despite low growth visibility (forward P/E, PEG, and profit-margin fields are null).
• Market cap is 30.50B with 483.40M shares outstanding; institutional ownership is 48.71%, indicating moderate institutional presence.
• Dividend yield is 0.34% (rate 0.22, ex-date 2026-05-06) — minimal income contribution.
• Beta is 0.43 (low volatility relative to market); 52-week range is 61.84 to 87.64, with current price near the low end.
• Missing fields (revenue growth, margins, ROE, debt/equity, FCF, analyst target) prevent full quality assessment; fundamental picture shows rich multiple with unclear growth support.
• Fundamentals diverge from technicals: high P/E suggests premium pricing, but price sits near 52-week low and below major SMAs, reflecting weak market conviction.

Current Market Position

Current price per indicators is 64.29 (as of 2026-10-12 close 64.29; minute bars show 2026-10-13 15:00 close at 63.12). Recent daily history shows decline from 72.06 (2026-08-31) to 64.29, with 30-day low 62.43 and high 73.52.

Minute bars (2026-10-12 09:30 to 2026-10-13 15:00) show open 64.28 → low 63.94 (early) → closed lower at 63.12 on 10-13; intraday momentum is mildly downward with low volumes (8k–14k per bar vs 20d avg 1.38M daily).

Technical Analysis

SMA alignment is bearish: price (64.29) < SMA 5 (63.52? actually price > SMA5 but < SMA20 64.69 and < SMA50 68.89) — corrected: SMA 5 (63.52) < Price (64.29) < SMA 20 (64.69) < SMA 50 (68.89), showing near-term bounce but broader downtrend. No golden/death cross on given data. RSI 40.31 indicates weak momentum, not oversold. MACD negative with histogram -0.27 confirms bearish pressure. Bollinger mid 64.69, price inside lower half; no squeeze (bands 62.45–66.92). 30-day range: price at 64.29 is 17% above low, 23% below high.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only) is Bearish. Call dollar vol 31,845 (1.9%) vs put dollar vol 1,635,095 (98.1%); 93 call contracts vs 5,030 put contracts. Conviction is heavily directional put-side.

Call Volume: $31,845 (1.9%) Put Volume: $1,635,095 (98.1%) Total: $1,666,940

Pure positioning suggests near-term downside expectations; aligns with technical downtrend, no divergence (both bearish).

Key Price Levels (Observational Only)